APA (7th ed.) Citation

Oksuz, S., Kinikoglu, O., Ozkerim, U., Isik, D., Surmeli, H., Ay, S., . . . Turan, N. (2026). Association between GRIm score and response to nivolumab monotherapy in patients with advanced malignant melanoma. Journal of Cancer Research & Clinical Oncology, 152(1), 1. https://doi.org/10.1007/s00432-025-06411-7

Chicago Style (17th ed.) Citation

Oksuz, Sila, et al. "Association Between GRIm Score and Response to Nivolumab Monotherapy in Patients with Advanced Malignant Melanoma." Journal of Cancer Research & Clinical Oncology 152, no. 1 (2026): 1. https://doi.org/10.1007/s00432-025-06411-7.

MLA (9th ed.) Citation

Oksuz, Sila, et al. "Association Between GRIm Score and Response to Nivolumab Monotherapy in Patients with Advanced Malignant Melanoma." Journal of Cancer Research & Clinical Oncology, vol. 152, no. 1, 2026, p. 1, https://doi.org/10.1007/s00432-025-06411-7.